Health Care·Pharmaceuticals·$547.6B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.30 | N/A | +0.78% |
management commentary, guidance changes, and full analysis available with Pro.
| +0.78% |
Tone: Cautiously Optimistic
Management expressed satisfaction with the earnings results, highlighting their commitment to quality. However, they did not provide specific guidance for future quarters.
We are pleased with our performance this quarter.
Our focus remains on delivering quality products to our customers.
This earnings report indicates that Johnson & Johnson performed better than expected on earnings per share, which is a positive sign for the company. However, the lack of revenue data and guidance leaves some uncertainty about future performance. The stock reaction is not available, making it difficult to assess immediate market sentiment.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
PACKAGING CORP AMER
Jul 16, 2012